Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP816771.RA1fyhSwhlL5tG_s40bIRZaEO78nzUprOta84wDChAXl8130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP816771.RA1fyhSwhlL5tG_s40bIRZaEO78nzUprOta84wDChAXl8130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP816771.RA1fyhSwhlL5tG_s40bIRZaEO78nzUprOta84wDChAXl8130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP816771.RA1fyhSwhlL5tG_s40bIRZaEO78nzUprOta84wDChAXl8130_provenance.
- NP816771.RA1fyhSwhlL5tG_s40bIRZaEO78nzUprOta84wDChAXl8130_assertion description "[Significant use of selective cyclooxygenase-2 (COX-2) blocking agents prescribed for the treatment of arthritis during 1999 to 2005 facilitates epidemiologic investigations to illuminate their chemopreventive effects against human cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP816771.RA1fyhSwhlL5tG_s40bIRZaEO78nzUprOta84wDChAXl8130_provenance.
- NP816771.RA1fyhSwhlL5tG_s40bIRZaEO78nzUprOta84wDChAXl8130_assertion evidence source_evidence_literature NP816771.RA1fyhSwhlL5tG_s40bIRZaEO78nzUprOta84wDChAXl8130_provenance.
- NP816771.RA1fyhSwhlL5tG_s40bIRZaEO78nzUprOta84wDChAXl8130_assertion SIO_000772 17612052 NP816771.RA1fyhSwhlL5tG_s40bIRZaEO78nzUprOta84wDChAXl8130_provenance.
- NP816771.RA1fyhSwhlL5tG_s40bIRZaEO78nzUprOta84wDChAXl8130_assertion wasDerivedFrom befree-20140225 NP816771.RA1fyhSwhlL5tG_s40bIRZaEO78nzUprOta84wDChAXl8130_provenance.
- NP816771.RA1fyhSwhlL5tG_s40bIRZaEO78nzUprOta84wDChAXl8130_assertion wasGeneratedBy ECO_0000203 NP816771.RA1fyhSwhlL5tG_s40bIRZaEO78nzUprOta84wDChAXl8130_provenance.
- befree-20140225 importedOn "2014-02-25" NP816771.RA1fyhSwhlL5tG_s40bIRZaEO78nzUprOta84wDChAXl8130_provenance.